Trial Profile
A Pilot Study of the Effects of High-Dose Oral Calcitriol in Breast Cancer Patients Prior to Surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Apr 2022
Price :
$35
*
At a glance
- Drugs Calcitriol (Primary)
- Indications Osteoporosis
- Focus Biomarker; Therapeutic Use
- 30 Mar 2022 Status changed from active, no longer recruiting to completed.
- 01 Mar 2021 Planned End Date changed from 1 Dec 2020 to 1 Dec 2021.
- 17 Nov 2020 Planned End Date changed from 1 Oct 2020 to 1 Dec 2020.